Evaluating the Long Term Immunogenicity of Ebola Virus Vaccines Ad26-ZEBOV, MVA-BN-Filo and rVSV-ZEBOV
Phase of Trial: Phase I
Latest Information Update: 20 Nov 2018
At a glance
- Drugs Ad26 EBOV vaccine (Primary) ; Modified Vaccinia Ankara Bavarian Nordic Ebola Marburg vaccine (Primary) ; RVSV-S-GP/VP40 vaccine (Primary)
- Indications Ebola virus infections
- Focus Pharmacodynamics
- Acronyms PRISM
- 06 Nov 2018 Planned number of patients changed from 152 to 169.
- 06 Nov 2018 Planned End Date changed from 30 Nov 2019 to 31 Jul 2020.
- 06 Nov 2018 Planned primary completion date changed from 30 Nov 2019 to 31 Jul 2020.